Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas

Martee L Hensley1, Brigitte A Barrette, Klaus Baumann

  • 1*Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY; †Mayo Clinic, Rochester, MN, GOG; ‡Gynäkologische Endokrinologie und Onkologie Universitätsklinikum Gießen und Marburg GmbH, AGO; §Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT, RTOG; ∥Peter MacCallum Cancer Centre, Royal Women's Hospital, University of Melbourne, Melbourne, Australia, ANZOG; ¶Seoul National University College of Medicine, KGOG; #University of Tampere, Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland, NSGO; **Institut Gustave-Roussy, Villejuif, France, GINECO; ††NHS Greater Glasgow and Clyde, Glasgow Royal Infirmary, Glasgow, Scotland, SGCTG; ‡‡Academic Medical Center, Amsterdam, Netherlands, DGOG; §§Centre Léon Bérard, Lyon, GINECO.

Abstract